First Tracks Biotherapeutics Inc

TRAX | NASDAQ

$43.95

-$1.13 (-2.51%)

Nov 2, 2026, 11:27 AM ET · Market open

Fiscal Quarter Period Ending	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q1 2025 Mar 31, 2025
Revenue	n/a	n/a	n/a
Cost of Revenue	207K	n/a	n/a
Gross Profit	-207K	n/a	n/a
Operating Income	-34.94M	-52.81M	-51.28M
Interest Income	1.56M	2.33M	4.09M
Pretax Income	-33.37M	-50.48M	-47.2M
Net Income	-33.37M	-50.48M	-47.2M
Selling & General & Admin	9.19M	18.86M	9.82M
Research & Development	25.54M	33.96M	41.47M
Other Expenses	n/a	n/a	n/a
Operating Expenses	34.73M	52.81M	51.28M
Interest Expense	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	34.94M	52.81M	51.28M
Income Tax Expense	n/a	n/a	n/a
Shares Outstanding (Basic)	35.39M	34.75M	34.75M
Shares Outstanding (Diluted)	35.39M	34.75M	34.75M
EPS (Basic)	-0.94	-1.45	-1.36
EPS (Diluted)	-0.94	-1.45	-1.36
EBITDA	-34.73M	-52.69M	-50.67M
EBIT	-34.94M	-52.81M	-51.28M
Depreciation & Amortization	207K	125K	606K